Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06668909 · ClinicalTrials.gov registry record
Patient Reported Outcomes With WaveLight LASIK
A clinical trial of Myopia, sponsored by OVO LASIK + Lens.
- Completed
- Registry status
- 300
- Enrollment target
- 4
- Study locations
NCT06668909: Completed study of Myopia, sponsored by OVO LASIK + Lens.
NCT06668909 is a study of Myopia that has completed, run by OVO LASIK + Lens. The registered enrollment target is 300 participants, above the 265-participant average among 90 other Myopia trials with a reported enrollment target (13% higher). The trial reports 4 study locations across 4 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06668909, a study of Myopia, has completed, sponsored by OVO LASIK + Lens.
- COMPLETED
- Registry status
- 300 participants
- Enrollment target
- 4
- Study locations
Study Summary
This study is a multi-site, single-arm, ambispective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed 12+ months post-operatively. Clinical evaluations will include administration of the OSDI, modified PROWL, and dry eye questionnaires.
Primary Outcome
Percentage of subjects satisfied (Completely Satisfied or Very Satisfied) with vision after Wavelight LASIK based on a modified PROWL Questionnaire (Question #1 only).
Conditions Studied
Interventions
- DEVICE WaveLight® EX500
Study Locations (4)
California
- NVISION Eye Centers - San Diego
Massachusetts
- Boston Vision - Brookline
Minnesota
- Ovo Lasik + Lens - Saint Louis Park
Texas
- Mann Eye Institute - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2024-11-01 |
| Est. Completion | 2025-02-14 |
What the finished NCT06668909 record still lists
NCT06668909 is an observational study that tracks outcomes without assigning an intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, above the 265-participant average among 90 other Myopia trials with a reported enrollment target (13% higher).
The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 1 intervention - of which WaveLight® EX500 is the first listed.
NCT06668909 reports a single indexed study location in California, Massachusetts, Minnesota.
Frequently Asked Questions
What is clinical trial NCT06668909 about?
NCT06668909 is a clinical study titled "Patient Reported Outcomes With WaveLight LASIK". This study is a multi-site, single-arm, ambispective, observational study of subject satisfaction, after successful bilateral LASIK surgery. Subjects will be assessed 12+ months post-operatively. Clinical evaluations will include administration of the OSDI, modified PROWL, and dry eye questionnaires...
What is the current status of trial NCT06668909?
This trial is currently completed. The enrollment target is 300 participants. The study started on 2024-11-01. Estimated completion is 2025-02-14.
What conditions does trial NCT06668909 study?
This clinical trial studies the following conditions: Myopia.
What interventions are being tested in trial NCT06668909?
The interventions under investigation include: WaveLight® EX500 (DEVICE).
Who is sponsoring clinical trial NCT06668909?
This trial is sponsored by OVO LASIK + Lens, which has 2 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06668909 being conducted?
This trial has 4 study locations across California, Massachusetts, Minnesota, Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Myopia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06668909's enrollment target sits among peer trials
300 18th of 90 higher than 73 of 90 other Myopia trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Myopia trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Efficacy of Repeated Low-level Red-light Therapy in Myopia Control
RECRUITING · NA
-
Comprehensive Assessment of Multiple Products (CAMP)
RECRUITING · NA
-
Children's Viewing Behavior
RECRUITING · NA
-
Clinical Evaluation of WaveLight Plus LASIK
RECRUITING
-
Violet Light for the Suppression of Myopia
RECRUITING · NA
-
Measuring Outcomes of LASIK and EVO-ICL in Matched Populations
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI